Showing 41 - 60 results of 239 for search '"circulating tumour cells"', query time: 0.48s Refine Results
  1. 41
  2. 42
  3. 43

    Gene expression of circulating tumour cells and its correlation with tumour stage in breast cancer patients by Bölke E, Orth K, Gerber PA, Lammering G, Mota R, Peiper M, Matuschek C, Budach W, Rusnak E, Shaikh S, Dogan B, Prisack HB, Bojar H

    Published 2009-09-01
    “…The analyses of circulating tumour cells may provide important prognostic information in the clinical setting.…”
    Get full text
    Article
  4. 44
  5. 45
  6. 46

    Circulating tumour cells at baseline and late phase of treatment provide prognostic value in breast cancer by Shuyun Pang, Hanjun Li, Shu Xu, Liying Feng, Xueping Ma, Yanan Chu, Bingjie Zou, Shaohua Wang, Guohua Zhou

    Published 2021-06-01
    “…Abstract To determine the prognostic value of the timing of circulating breast tumour cell measurement during treatment, peripheral blood from 164 patients with breast disease was collected. Circulating tumour cells (CTCs) were enriched by using immunomagnetic nanospheres (IMNs) and were identified by using immunofluorescent staining. …”
    Get full text
    Article
  7. 47
  8. 48
  9. 49
  10. 50
  11. 51

    Circulating tumour cells as an indicator of early and systemic recurrence after surgical resection in pancreatic ductal adenocarcinoma by Yejong Park, Hye Ryeong Jun, Hwi Wan Choi, Dae Wook Hwang, Jae Hoon Lee, Ki Byung Song, Woohyung Lee, Jaewoo Kwon, Su Hyeon Ha, Eunsung Jun, Song Cheol Kim

    Published 2021-01-01
    “…We determined in our current study whether circulating tumour cells (CTCs) exist in the blood of PDAC patients and can be used as a predictor of recurrence patterns (i.e. time and site) after surgical resection. …”
    Get full text
    Article
  12. 52
  13. 53

    Novel Circulating Tumour Cell-Related Risk Model Indicates Prognosis and Immune Infiltration in Lung Adenocarcinoma by Lu Liang, Yueying Liu, Shiyao Jiang, Jingjing Huang, Hua He, Li Shen, Li Cong, Yiqun Jiang

    Published 2022-01-01
    “…LUAD has a low survival rate owing to tumour invasion and metastasis. Circulating tumour cells (CTCs) are precursors of distant metastasis, which are considered to adopt the characteristics of cancer stem cells (CSCs). …”
    Get full text
    Article
  14. 54
  15. 55
  16. 56
  17. 57
  18. 58
  19. 59
  20. 60